{"id":764866,"date":"2023-06-20T16:08:09","date_gmt":"2023-06-20T20:08:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/"},"modified":"2023-06-20T16:08:09","modified_gmt":"2023-06-20T20:08:09","slug":"insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/","title":{"rendered":"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom"},"content":{"rendered":"

<\/p>\n

Insulet Announces Omnipod<\/b>\u00ae<\/sup> 5 Automated Insulin Delivery System is Now Available in the United Kingdom<\/b><\/p>\n

ACTON, Mass.–(BUSINESS WIRE<\/a>)–
\nInsulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology<\/a> with its Omnipod\u00ae<\/sup> brand of products, today announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D) in the United Kingdom (UK).<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230620673527\/en\/<\/a><\/p>\n

\"Omnipod\u00ae<\/p>\n

Omnipod\u00ae 5 Automated Insulin Delivery System (Photo: Business Wire)<\/p>\n<\/div>\n

\n\u201cSince its commercial launch in the United States, Omnipod 5 has had a remarkable impact on people with diabetes,\u201d said Jim Hollingshead, Insulet President and CEO. \u201cEvery day, we hear how this revolutionary experience of Omnipod 5 reduces the burden and improves quality of life for people with diabetes, and we are excited to make a difference in other parts of the world, beginning with the UK. We are committed to making Omnipod 5 an option for as many people as possible, as quickly as we can, and working hard to secure broad access globally.\u201d<\/p>\n

\nThe Omnipod 5 System is where simplicity meets advanced technology. Omnipod 5 is the first CE marked tubeless hybrid closed loop system (also known as automated insulin delivery) that integrates with the Dexcom G6 Continuous Glucose Monitoring (CGM) System to automatically adjust insulin delivery and help protect against high and low glucose levels1<\/sup>. The system2<\/sup> consists of the tubeless Pod enhanced with SmartAdjust\u2122 technology and the Omnipod 5 Controller with its integrated SmartBolus Calculator. The system is interoperable with the Dexcom G6 CGM for automated insulin delivery.<\/p>\n

\nEvery five minutes, SmartAdjust technology receives a CGM value and trend, and predicts where glucose will be 60 minutes into the future. The system then increases, decreases, or pauses insulin delivery based on the user\u2019s desired and customized glucose target. Omnipod 5 simplifies daily diabetes management by making many of these dosing decisions for the user, while they focus on other aspects of their life.<\/p>\n

\nLydia Parkhurst, a 26-year-old geography teacher who enjoys backpacking and has travelled the world with her Omnipod DASH\u00ae<\/sup> System, has been a Podder since 2015. \u201cI am so excited for the release of Omnipod 5 in the UK,\u201d said Lydia. \u201cI can\u2019t wait to experience the freedom of being tubeless while also having the support of hybrid closed loop technology. The combination will make living with type 1 diabetes far less complicated \u2013 allowing me to live my life to the fullest!\u201d<\/p>\n

\n\u201cWith NICE3<\/sup> set to approve hybrid closed loop in England and Wales later this year, we are delighted that more hybrid closed loop systems such as Omnipod 5 are becoming available to help people manage their type 1 diabetes,\u201d said Karen Addington, CEO at JDRF UK. \u201cDiabetes management is very personal, so access to a range of technology options is crucial. A wider choice of hybrid closed loop systems offers people with type 1 diabetes evidence-based treatment they can trust to support them to manage their condition with confidence.\u201d<\/p>\n

\nInsulet is working in partnership with the National Health Service (NHS) at all levels to ensure access to Omnipod 5 for people with type 1 diabetes.<\/p>\n

\nInsulet plans to release Omnipod 5 in Germany in the fall of 2023.<\/p>\n

\nTo learn more about Omnipod 5, visit the Omnipod website<\/a>.<\/p>\n

1<\/sup><\/i>Study in 240 people with T1D aged 6 to 70 years involving two weeks standard diabetes therapy followed by three months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults\/adolescents and children, standard therapy vs. three-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults\/adolescents and children, standard therapy vs. three-month Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Brown et. al. Diabetes Care (2021).<\/i>Study in 80 children with T1D aged 2 to 5.9 years involving two weeks of standard diabetes therapy followed by three months Omnipod 5 use in Automated Mode. Average overnight time (12AM-6AM) with high blood glucose in children for standard therapy vs. Omnipod 5 was 38.4% vs. 16.9%. Average day time (6AM-12AM) with high blood glucose in children for standard therapy vs. Omnipod 5 was 39.4% vs. 29.5%. Median overnight time (12AM-6AM) with low blood glucose in children for standard therapy vs. Omnipod 5 was 3.41% vs. 2.13%. Median day time (6AM-12AM) with low blood glucose in children for standard therapy vs. Omnipod 5 was 3.43% vs. 2.46%. Sherr J, et. al. Diabetes Care (2022).<\/i><\/p>\n

2<\/sup>Integration with the Dexcom G6 CGM is required for automated insulin delivery.<\/i><\/p>\n

3<\/sup>National Institute of Health and Care Excellence.<\/i><\/p>\n

About Insulet Corporation:<\/i><\/b><\/p>\n

\nInsulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet\u2019s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible smartphone or Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com<\/a> and omnipod.com<\/a>.<\/p>\n

Forward-Looking Statement:<\/i><\/b><\/p>\n

\nThis press release may contain forward-looking statements concerning Insulet’s expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on its current expectations and beliefs concerning future developments and their potential effects on Insulet. There can be no assurance that future developments affecting Insulet will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond its control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, and other risks and uncertainties described in its Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on February 24, 2023 in the section entitled “Risk Factors,” and in its other filings from time to time with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.<\/p>\n

\n\u00a92023 Insulet Corporation. Omnipod, Omnipod DASH, Omnipod 5, and SmartAdjust are trademarks or registered trademarks of Insulet Corporation in the United States of America and various other jurisdictions. All rights reserved. All other trademarks are the property of their respective owners. The use of third-party trademarks does not constitute an endorsement or imply a relationship or other affiliation.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230620673527\/en\/<\/a><\/span><\/p>\n

Investor Relations:
\n<\/i><\/b>
Deborah R. Gordon
\n
Vice President, Investor Relations
\n
(978) 600-7717
\n
dgordon@insulet.com<\/a><\/p>\n

Media:
\n<\/i><\/b>
Angela Geryak Wiczek
\n
Senior Director, Corporate Communications
\n
(978) 932-0611
\n
awiczek@insulet.com<\/a><\/p>\n

KEYWORDS:<\/b> North America United States Ireland United Kingdom Europe Massachusetts<\/p>\n

INDUSTRY KEYWORDS:<\/b> Diabetes Health Medical Devices<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
Omnipod\u00ae 5 Automated Insulin Delivery System (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom ACTON, Mass.–(BUSINESS WIRE)– Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D) in the United Kingdom (UK). This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230620673527\/en\/ Omnipod\u00ae 5 Automated Insulin Delivery System (Photo: Business Wire) \u201cSince its commercial launch in the United States, Omnipod 5 has had a remarkable impact on people with diabetes,\u201d said Jim Hollingshead, Insulet President and CEO. \u201cEvery day, … <\/p>\n

Continue reading “Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-764866","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nInsulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom ACTON, Mass.–(BUSINESS WIRE)– Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D) in the United Kingdom (UK). This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230620673527\/en\/ Omnipod\u00ae 5 Automated Insulin Delivery System (Photo: Business Wire) \u201cSince its commercial launch in the United States, Omnipod 5 has had a remarkable impact on people with diabetes,\u201d said Jim Hollingshead, Insulet President and CEO. \u201cEvery day, … Continue reading "Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-20T20:08:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230620673527\/en\/1822586\/4\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom\",\"datePublished\":\"2023-06-20T20:08:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/\"},\"wordCount\":1200,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230620673527\\\/en\\\/1822586\\\/4\\\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/\",\"name\":\"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230620673527\\\/en\\\/1822586\\\/4\\\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg\",\"datePublished\":\"2023-06-20T20:08:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230620673527\\\/en\\\/1822586\\\/4\\\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230620673527\\\/en\\\/1822586\\\/4\\\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/","og_locale":"en_US","og_type":"article","og_title":"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom - Market Newsdesk","og_description":"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom ACTON, Mass.–(BUSINESS WIRE)– Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D) in the United Kingdom (UK). This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230620673527\/en\/ Omnipod\u00ae 5 Automated Insulin Delivery System (Photo: Business Wire) \u201cSince its commercial launch in the United States, Omnipod 5 has had a remarkable impact on people with diabetes,\u201d said Jim Hollingshead, Insulet President and CEO. \u201cEvery day, … Continue reading \"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-20T20:08:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230620673527\/en\/1822586\/4\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom","datePublished":"2023-06-20T20:08:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/"},"wordCount":1200,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230620673527\/en\/1822586\/4\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/","name":"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230620673527\/en\/1822586\/4\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg","datePublished":"2023-06-20T20:08:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230620673527\/en\/1822586\/4\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230620673527\/en\/1822586\/4\/OP5_INSU_POD_PDM_NoADH_DEX_LEFT_RGB-EN-mmol.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-omnipod-5-automated-insulin-delivery-system-is-now-available-in-the-united-kingdom\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Insulet Announces Omnipod\u00ae 5 Automated Insulin Delivery System is Now Available in the United Kingdom"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/764866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=764866"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/764866\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=764866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=764866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=764866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}